Platinum-based chemo may improve survival for some metastatic pancreatic cancer patients
Bottom Line: Patients with metastatic pancreatic cancer who had germline or somatic mutations in DNA repair genes had better clinical outcomes after platinum-based chemotherapy, as compared with patients without these mutations. Journal in Which the Study was Published: Clinical Cancer Research, a journal of the American Association for Cancer Research Authors: The senior author was…
Details